Integrating fingerprints: molecular phenotyping of severe asthma

Bertrand De Meulder (Lyon, France)

Source: International Congress 2015 – Fingerprinting severe asthma
Session: Fingerprinting severe asthma
Session type: Symposium
Number: 3458
Disease area: Airway diseases

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bertrand De Meulder (Lyon, France). Integrating fingerprints: molecular phenotyping of severe asthma. International Congress 2015 – Fingerprinting severe asthma

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Metabolic profiling of severe asthma: implications for phenotyping and treatment
Source: ERS Lung Science Conference 2020
Year: 2020

Metabolomics for molecular phenotyping in respiratory disease
Source: ERS Lung Science Conference 2016
Year: 2016

Omics in population studies: a molecular epidemiology perspective in chronic airway disease
Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Year: 2014



New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


From genetical genomics to system genetics: application in asthma/COPD
Source: ERS Research Seminar 2015
Year: 2015

Ykl-40 and phenotyping of severe asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


Lipidomic phenotyping of severe asthma
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014

Paediatric severe asthma: a need for novel innate molecular phenotypes
Source: Eur Respir J, 54 (2) 1901459; 10.1183/13993003.01459-2019
Year: 2019



Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



Improved definition of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006

Integration of multi-omics datasets enables molecular classification of COPD
Source: Eur Respir J, 51 (5) 1701930; 10.1183/13993003.01930-2017
Year: 2018



Monitoring asthma in children: clinical tools
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014



Defining the clinical clusters of severe asthma within UBIOPRED
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015



Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018